Puncture-Resistant Protected Inner Container Device
Executive Overview
This invention introduces a regulation-compliant, additive-free, protected glass blood collection system designed for high-value regenerative medicine applications, particularly Platelet-Rich Fibrin (PRF) and autologous blood therapies.
The device solves a major industry conflict:
- Glass tubes naturally activate clotting (ideal for PRF) but are unsafe and discouraged by OSHA/CDC, FDA, NIOSH.
- Plastic (PET) tubes are safer but require silica coatings and/or other coats / additives, which introduce contamination risk and regulatory limitations to autologous blood purity laws.
This patented system enables continued use of plain glass tubes while providing a puncture-resistant, impact-absorbing protective housing, creating a safer, superior clinical solution.
Investment Thesis
The invention enables:
- Reintroduction of biologically superior glass tubes
- Compliance with modern safety standards
- Differentiation in a crowded PRP/PRF marketplace
- Expansion into global regenerative medicine markets
With regulatory pressure increasing and regenerative procedures growing, this technology addresses both safety and biological performance simultaneously — a rare alignment.
PRF Tubes
The Problem
Modern regenerative treatments (PRF, PRP, autologous concentrates):
- Require clot activation
- Must avoid foreign additives for blood purity laws
- Must comply with increasing safety regulations
- Involve repeated blood draws and centrifugation
Current options:
| Glass Tubes | Plastic Tubes |
|---|---|
| Natural clot activation | Require silica/additives |
| Additive-free | Chemical exposure risk |
| Risk of breakage | Lower breakage risk |
| Increasing regulatory pressure | Widely adopted but biologically inferior for PRF and lab use |
The market lacks a safe, additive-free, glass-based solution.
The Solution
A triple-sealed, impact-resistant protective system that fully encloses a glass blood collection tube while preserving:
- Natural clot activation
- Vacuum integrity
- Puncture-site access
- Centrifuge compatibility
Technical Architecture
The system integrates four coordinated components:
1. Impact-Resistant Outer Protective Body
- Elongated housing
- Internal cavity sized for glass tube
- Made from impact-absorbing material (e.g., silicone, polymer)
- Optional stabilizing base (ring, suction cup, or silicone feet)
- Designed to fit standard centrifuges
2. Plain Glass Inner Tube
- Non-reactive glass
- Promotes natural coagulation
- Eliminates need for silica clot activators
- Compatible with PRF/PRP workflows
3. Dual-Structure Rubber Stopper
- Upper and lower portions separated by groove
- Centrally located puncture site
- Forms primary vacuum seal
4. Outer Closure Cap (Key Innovation)
- Frictionally engages stopper and tube
- Locks into protective housing
- Creates second and third seals
- Simultaneously extracts stopper when removed
Core Innovation: Triple-Seal Safety System
The device creates:
- Primary seal – stopper to glass tube
- Secondary seal – closure cap to stopper and tube
- Tertiary seal – closure cap to protective housing
This architecture provides:
- Enhanced contamination control
- Fragment containment if glass breaks
- Controlled stopper removal
- Reduced occupational injury risk
- Allows glass tube contact-free verification
- Contact-free PRF tube rim validation
Differentiating Advantages
1. Additive-Free PRF Capability
- No silica coatings
- No clot activators
- No anticoagulants
- Maintains autologous purity
2. Regulatory Alignment
- Addresses OSHA/CDC discouragement of exposed glass tubes
- Preserves safety without sacrificing biological performance
3. Centrifuge-Compatible Protection
- Designed for spinning while enclosed
- Reduces breakage risk during centrifugation
4. Non-Destructive Rim Inspection
- Transparent embodiments allow glass integrity validation
- Upper rim exposure feature enables inspection before use
5. Enhanced Clinical Safety
- Breakage mitigation
- Laceration risk reduction
- Containment of fragments
- Sample integrity preservation
Market Opportunity
Primary Target Segments
- Dental and oral surgery (PRF)
- Orthopedic regenerative medicine
- Aesthetic medicine
- Hair restoration
- Autologous biologic therapies
- Advanced wound care
Market Drivers
- Growing regenerative medicine market
- Increased demand for additive-free biologics
- Regulatory tightening on contamination
- Premium pricing tolerance in PRF markets
PRF procedures alone are expanding rapidly in dentistry and surgical settings, often requiring multiple tubes per session.
Competitive Positioning
| Feature | Standard Glass | PET Plastic | This Device |
|---|---|---|---|
| Natural clot activation | Yes | No | Yes |
| Additive-free | Yes | No | Yes |
| OSHA-compliant | No | Yes | Yes |
| Breakage protection | No | Yes | Yes |
| Fragment containment | No | Yes | Yes |
| PRF optimized | Yes | Limited | Yes |
This positions the device as a premium safety-enhanced glass system, rather than a commodity tube.
IP Strength
- Broad structural independent claim
- Protection of triple-seal architecture
- Stopper extraction mechanism
- Aligned puncture-site configuration
- Stabilizing base embodiments
- Transparent inspection embodiments
- Sterile packaging claims
The invention does not merely claim a sleeve — it claims an integrated mechanical system with coordinated sealing and extraction functionality, including verification and validation procedures for safety.
Commercial Model
Potential monetization pathways:
- Premium disposable PRF kits
- Sterile multi-pack configurations
- White-label manufacturing for regenerative brands
- Licensing to dental supply companies
- OEM integration into centrifuge systems
Gross margins in regenerative consumables are typically high, especially for proprietary tube systems.
Strategic Value
This technology:
- Solves a regulatory-driven problem
- Enhances clinical safety
- Protects biological purity
- Targets a growing, premium medical segment
- Creates defensible IP around protected glass systems
It represents a category-creating solution:
“Protected Additive-Free Glass Regenerative Collection System.”
Investment Thesis
The invention enables:
- Reintroduction of biologically superior glass tubes
- Compliance with modern safety standards
- Differentiation in a crowded PRP/PRF marketplace
- Expansion into global regenerative medicine markets
With regulatory pressure increasing and regenerative procedures growing, this technology addresses both safety and biological performance simultaneously — a rare alignment.
New Patent
PRF Box patented technology – Precise repeatable PRF compression device
Problem
Current PRF systems rely on manual pressure, resulting in inconsistent membrane thickness and
unpredictable clinical outcomes.
Solution
A novel mechanical compression system that defines a fixed membrane thickness independent of
user-applied force, ensuring reproducibility.
Intellectual Property
U.S. non-provisional patent filed covering structural compression mechanism, fixed-gap control, and
integrated drainage.
Market
Targeting dental implantology, oral surgery, and regenerative medicine with increasing demand for
predictable biological solutions.
Business Model
Device sales plus recurring consumables (sterile trays, inserts) and licensing opportunities.
Competitive Advantage
Structurally defined compression thickness, improved reproducibility, integrated drainage, and strong
IP position.
Status
Patent filed, design complete, ready for prototyping and validation.
Vision
Establish a new standard for PRF membrane preparation through precise mechanical control.
Value Proposition
A patent-pending PRF system delivering consistent, high-quality membranes through precise
mechanical control.
Patented Biomedical device
PRF-BRGF System
